Array Biopharma Inc.
13F holders, Q2 2025 (June 30)1holders
0new positions
0sold out
$5.90avg. 13F price*
At the end of Q2 2025, 1 institutions reported holding Array Biopharma Inc. in their 13F filings, unchanged from Q1 2025. 0 opened new positions and 0 sold out. The largest holder was Cibc World Markets Corp. ($110K).
- Company
- Array Biopharma Inc.
- CUSIP
- 04269X105
- Latest filing quarter
- Q3 2025
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
All 13F filers, Q1 2025 → Q2 2025: 15,170 shares sold, net −15,170 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| Cibc World Markets Corp. | 0.00% | Reduce -44.8% | 18,718 | $110K |
"% of holder's portfolio" is ARRAY BIOPHARMA INC's weight in each manager's 13F, not the share of Array Biopharma Inc. the manager owns.